Clinical trial
Determining the Safety and Effectiveness of Olanzapine in Children and…
NCT00183612 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00183612 |
|---|---|
| Title | Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents |
| Official title | Developmental Pharmacokinetics of Psychotropic Drugs: Olanzapine |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Olanzapine |
| Enrollment | 68 |
| Start date | May 1, 2000 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 8, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: